These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 18061700)

  • 1. An initial pharmacokinetic study with a Metered Dose Transdermal Systemfor delivery of the progestogen Nestorone as a possible future contraceptive.
    Fraser IS; Weisberg E; Kumar N; Kumar S; Humberstone AJ; McCrossin L; Shaw D; Tsong YY; Sitruk-Ware R
    Contraception; 2007 Dec; 76(6):432-8. PubMed ID: 18061700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Nestorone and ethinyl estradiol levels, and ovulation inhibition in women using three different dosage combinations of a Nestorone progestogen-ethinyl estradiol contraceptive vaginal ring on a bleeding-signaled regimen.
    Fraser IS; Weisberg E; Brache V; Alvarez F; Massai R; Mishell DR; Apter D; Gale J; Tsong YY; Sivin I
    Contraception; 2005 Jul; 72(1):40-5. PubMed ID: 15964291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dose-finding, cross-over study to evaluate the effect of a Nestorone®/Estradiol transdermal gel delivery on ovulation suppression in normal ovulating women.
    Brache V; Merkatz R; Kumar N; Jesam C; Sussman H; Hoskin E; Roberts K; Alami M; Taylor D; Jorge A; Croxatto H; Lorange E; Mishell DR; Sitruk-Ware R
    Contraception; 2015 Oct; 92(4):289-97. PubMed ID: 26032952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transdermal delivery of sex steroids for hormone replacement therapy and contraception. A review of principles and practice.
    Henzl MR; Loomba PK
    J Reprod Med; 2003 Jul; 48(7):525-40. PubMed ID: 12953327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical performance and menstrual bleeding patterns with three dosage combinations of a Nestorone progestogen/ethinyl estradiol contraceptive vaginal ring used on a bleeding-signaled regimen.
    Weisberg E; Brache V; Alvarez F; Massai R; Mishell DR; Apter D; Gale J; Sivin I; Tsong YY; Fraser IS
    Contraception; 2005 Jul; 72(1):46-52. PubMed ID: 15964292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous dosing of a novel contraceptive vaginal ring releasing Nestorone® and estradiol: pharmacokinetics from a dose-finding study.
    Jensen JT; Edelman AB; Chen BA; Archer DF; Barnhart KT; Thomas MA; Burke AE; Westhoff CL; Wan LS; Sitruk-Ware R; Kumar N; Variano B; Blithe DL
    Contraception; 2018 May; 97(5):422-427. PubMed ID: 29409834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steady-state pharmacokinetics following application of a novel transdermal estradiol spray in healthy postmenopausal women.
    Morton TL; Gattermeir DJ; Petersen CA; Day WW; Schumacher RJ
    J Clin Pharmacol; 2009 Sep; 49(9):1037-46. PubMed ID: 19628730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contraceptive vaginal rings releasing Nestorone and ethinylestradiol: a 1-year dose-finding trial.
    Sivin I; Mishell DR; Alvarez F; Brache V; Elomaa K; Lähteenmäki P; Massai R; Miranda P; Croxatto H; Dean C; Small M; Nash H; Jackanicz TM
    Contraception; 2005 Feb; 71(2):122-9. PubMed ID: 15707562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new combination of testosterone and nestorone transdermal gels for male hormonal contraception.
    Ilani N; Roth MY; Amory JK; Swerdloff RS; Dart C; Page ST; Bremner WJ; Sitruk-Ware R; Kumar N; Blithe DL; Wang C
    J Clin Endocrinol Metab; 2012 Oct; 97(10):3476-86. PubMed ID: 22791756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined transdermal testosterone gel and the progestin nestorone suppresses serum gonadotropins in men.
    Mahabadi V; Amory JK; Swerdloff RS; Bremner WJ; Page ST; Sitruk-Ware R; Christensen PD; Kumar N; Tsong YY; Blithe D; Wang C
    J Clin Endocrinol Metab; 2009 Jul; 94(7):2313-20. PubMed ID: 19366848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parenteral administration of progestin Nestorone to lactating cynomolgus monkeys: an ideal hormonal contraceptive at lactation?
    Heikinheimo O; Ranta S; Moo-Young A; Lähteenmäki P; Gordon K
    Hum Reprod; 1999 Aug; 14(8):1993-7. PubMed ID: 10438416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral and transdermal hormonal contraception in women after kidney transplantation.
    Pietrzak B; Bobrowska K; Jabiry-Zieniewicz Z; Kaminski P; Wielgos M; Pazik J; Durlik M
    Transplant Proc; 2007 Nov; 39(9):2759-62. PubMed ID: 18021980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of skin-to-skin contact, application site washing, and sunscreen use on the pharmacokinetics of estradiol from a metered-dose transdermal spray.
    Schumacher RJ; Gattermeir DJ; Peterson CA; Wisdom C; Day WW
    Menopause; 2009; 16(1):177-83. PubMed ID: 18779758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventing secondary exposure to women from men applying a novel nestorone/testosterone contraceptive gel.
    Yuen F; Wu S; Thirumalai A; Swerdloff RS; Page ST; Liu PY; Dart C; Wu H; Blithe DL; Sitruk-Ware R; Long J; Bai F; Hull L; Bremner WJ; Anawalt BD; Wang C
    Andrology; 2019 Mar; 7(2):235-243. PubMed ID: 30556332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parenteral administration of progestins for hormonal replacement therapy.
    Nath A; Sitruk-Ware R
    Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):88-96. PubMed ID: 19340703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-year performance of a Nestorone-releasing contraceptive implant: a three-center study of 300 women.
    Sivin I; Croxatto H; Bahamondes L; Brache V; Alvarez F; Massai R; Schechter J; Ranta S; Kumar N; Wu E; Tejeda AS; Reyes V; Travers E; Allen A; Moo-Young A
    Contraception; 2004 Feb; 69(2):137-44. PubMed ID: 14759619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contraceptive efficacy and clinical performance of Nestorone implants in postpartum women.
    Massai MR; Díaz S; Quinteros E; Reyes MV; Herreros C; Zepeda A; Croxatto HB; Moo-Young AJ
    Contraception; 2001 Dec; 64(6):369-76. PubMed ID: 11834236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian function during use of Nestorone(R) subdermal implants.
    Brache V; Massai R; Mishell DR; Moo-Young AJ; Alvarez F; Salvatierra AM; Cochon L; Croxatto H; Robbins A; Faundes A
    Contraception; 2000 Mar; 61(3):199-204. PubMed ID: 10827334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormonal contraception: state of the art and future perspectives.
    Benagiano G; Bastianelli C; Farris M
    Minerva Ginecol; 2007 Jun; 59(3):241-70. PubMed ID: 17576403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian function during use of vaginal rings delivering three different doses of Nestorone.
    Brache V; Mishell DR; Lahteenmaki P; Alvarez F; Elomaa K; Jackanicz T; Faundes A
    Contraception; 2001 May; 63(5):257-61. PubMed ID: 11448466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.